Israel - Hebräisch - Ministry of Health

"דין ציוד רפואי בע""מ" - אחר - "לשימוש במוסדות רפואיים מרפאות, בתי חולים ,בתי מרקחת ומוסדות סיעודיים"

Israel - Hebräisch - Ministry of Health

דין ציוד רפואי - אחר - לשימוש במוסדות רפואיים מרפאות, בתי חולים ,בתי מרקחת ומוסדות סיעודיים

Israel - Hebräisch - Ministry of Health

pfizer pharmaceuticals israel ltd - inotuzumab ozogamicin - אבקה להכנת תמיסה מרוכזת לעירוי - inotuzumab ozogamicin 1 mg/vial - inotuzumab ozogamicin

Israel - Hebräisch - Ministry of Health

pfizer pharmaceuticals israel ltd - gemtuzumab ozogamicin - אבקה להכנת תמיסה מרוכזת לעירוי - gemtuzumab ozogamicin 5 mg/vial - gemtuzumab

Israel - Hebräisch - Ministry of Health

pfizer pharmaceuticals israel ltd - bevacizumab - תרכיז להכנת תמיסה לאינפוזיה - bevacizumab 25 mg / 1 ml - bevacizumab

Israel - Hebräisch - Ministry of Health

pharmabest import (2003) ltd, israel - potassium citrate - טבליות עם שחרור נרחב - potassium citrate 1080 mg - potassium citrate

Israel - Hebräisch - Ministry of Health

padagis israel agencies ltd, israel - infliximab - אבקה להכנת תמיסה מרוכזת לעירוי - infliximab 100 mg/vial - infliximab

Israel - Hebräisch - Ministry of Health

pfizer pharmaceuticals israel ltd - taliglucerase alfa - אבקה להכנת תמיסה לאינפוזיה - taliglucerase alfa 200 u/vial - taliglucerase alfa - taliglucerase alfa - elelyso (taliglucerase alfa ) for injection is a hydrolytic lysosomal glucocerebroside - specific enzyme indicated for long - term enzyme replacement therapy (ert) for adults with a confirmed diagnosis of type 1 gaucher disease.

Israel - Hebräisch - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

Israel - Hebräisch - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 2000 iu / 1 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob